We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01559623
Recruitment Status : Completed
First Posted : March 21, 2012
Last Update Posted : December 16, 2014
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to assess the prevalence of mycoplasma hominis, ureaplasma urealyticum, neisseria gonorrhea, and chlamydia trachomatis in women with overactive bladder symptoms, and to correlate these findings with cystoscopic and urodynamic findings.

Condition or disease Intervention/treatment
Overactive Bladder Syndrome Procedure: retrospective data analysis

Study Design

Study Type : Observational
Actual Enrollment : 766 participants
Time Perspective: Retrospective
Study Start Date : January 2009
Primary Completion Date : December 2011
Study Completion Date : February 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Gonorrhea
U.S. FDA Resources

Groups and Cohorts

Intervention Details:
    Procedure: retrospective data analysis
    retrospective data analysis

Outcome Measures

Primary Outcome Measures :
  1. prevalence of ureaplasma urealyticum [ Time Frame: time of urogynecologic assessment ]
  2. prevalence of mycoplasma hominis [ Time Frame: time of urogynecologic assessment ]
  3. prevalence of neisseria gonorrhea [ Time Frame: time of urogynecologic assessment ]
  4. prevalence of chlamydia trachomatis [ Time Frame: time of urogynecologic assessment ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
clinic for urogynecology
Criteria

Inclusion criteria:

  • women with urogynecologic and urodynamic examination at our institution between 1.1.2009 and 31.12.2011

Exclusion criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01559623


Locations
Switzerland
University Hospital Zurich, Gynecology
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: David Amos Scheiner, MD University Hospital Zurich, Division of Gynecology
More Information

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01559623     History of Changes
Other Study ID Numbers: OAB2012
First Posted: March 21, 2012    Key Record Dates
Last Update Posted: December 16, 2014
Last Verified: December 2014

Additional relevant MeSH terms:
Urinary Bladder, Overactive
Lower Urinary Tract Symptoms
Urinary Bladder Diseases
Urologic Diseases
Urological Manifestations
Signs and Symptoms